Fas ligand upregulation is an early event in colonic carcinogenesis

Lignende værker

• Fas ligand mediates immune privilege and not inflammation in human colon cancer, irrespective of TGF-β expression
  af: Houston, A, et al.
  Udgivet: (2003)
• Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer
  af: Bennett, M, et al.
  Udgivet: (1999)
• Gastric cancer cell lines lack Fas ligand (FasL) expression but kill T cells via a FasL independent pathway
  af: TINHOFER, I, et al.
  Udgivet: (2000)
• Expression of Fas (CD95/APO-1) Ligand by Human Breast Cancers: Significance for Tumor Immune Privilege
  af: O’Connell, Joe, et al.
  Udgivet: (1999)
• The Fas counterattack: a molecular mechanism of tumor immune privilege.
  af: O'Connell, J., et al.
  Udgivet: (1997)